Response patterns to MEK inhibition, but not NRAS mutation status predict the efficacy of combined MEK/CDK4,6 targeting in melanomaC. Posch,M. Sanlorenzo,J. Ma,S. T. Kim, M. Zekhtser,K. Rappersberger,S. Ortiz-UrdaEXPERIMENTAL DERMATOLOGY（2017）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
